Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study
-
Published:2024-04
Issue:
Volume:39
Page:100862
-
ISSN:2666-7762
-
Container-title:The Lancet Regional Health - Europe
-
language:en
-
Short-container-title:The Lancet Regional Health - Europe
Author:
Günther René, Wurster Claudia Diana, Brakemeier Svenja, Osmanovic Alma, Schreiber-Katz Olivia, Petri Susanne, Uzelac Zeljko, Hiebeler Miriam, Thiele Simone, Walter Maggie C., Weiler MarkusORCID, Kessler Tobias, Freigang Maren, Lapp Hanna Sophie, Cordts Isabell, Lingor PaulORCID, Deschauer Marcus, Hahn Andreas, Martakis KyriakosORCID, Steinbach Robert, Ilse Benjamin, Rödiger Annekathrin, Bellut Julia, Nentwich Julia, Zeller Daniel, Muhandes Mohamad Tareq, Baum Tobias, Christoph Koch Jan, Schrank Bertold, Fischer Sophie, Hermann AndreasORCID, Kamm Christoph, Naegel Steffen, Mensch Alexander, Weber Markus, Neuwirth Christoph, Lehmann Helmar C., Wunderlich Gilbert, Stadler Christian, Tomforde Maike, George Annette, Groß Martin, Pechmann Astrid, Kirschner Janbernd, Türk Matthias, Schimmel Mareike, Bernert Günther, Martin Pascal, Rauscher Christian, Meyer zu Hörste Gerd, Baum Petra, Löscher Wolfgang, Flotats-Bastardas Marina, Köhler Cornelia, Probst-Schendzielorz Kristina, Goldbach Susanne, Schara-Schmidt Ulrike, Müller-Felber Wolfgang, Lochmüller Hanns, von Velsen Otgonzul, Kleinschnitz Christoph, Ludolph Albert C., Hagenacker TimORCID
Funder
Novartis Pharma AG Roche Biogen Inc
Subject
Health Policy,Oncology,Internal Medicine
|
|